Parallax Health accepting US orders for its coronavirus Point-of-Care diagnostics kits

Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Monday it is accepting orders for its coronavirus Point-of-Care diagnostics kits for US medical practices, hospitals, nursing operations, emergency centers, and nursing homes.  In a statement, the company also said it is providing immediate availability and access to Personal Protection Equipment (PPE) including, but not limited to, FDA-approved medical masks, protective sterile gowns, eye-protecting goggles, face shields, ventilators, and other medical grade equipment.  Parallax will also provide free downloads of its patented Good Health Outcomes Remote Patient Monitoring (RPM) platform that enables comprehensive telehealth capabilities. READ: Parallax subsidiary makes telemedicine app immediately available to US doctors as coronavirus spreads The company, whose subsidiary has signed a contract with a medical distribution company in China, said it has created a Government and Medical Practice website to process orders immediately. It has access to large inventories of all the available products and is offering the products in all 50 states and all US territories from the company’s website at www.goodhealthoutcomes.com. “Our Good Health Outcomes remote patient monitoring application is the only system that has our patented Data-Driven Outcome and FotoDigm technology,” said Parallax's president Nathaniel Bradley. “These capabilities allow us to capture in real-time the test results achieved from the test kits we are offering through this partnership today. Further, our platform enables care providers to communicate with patients remotely and conserve their use of PPE and serve the communities of the US remotely, leveraging encrypted and Health Insurance Portability and Accountability Act, compliant video, audio and data communications.” CEO Paul Arena noted the Parallax was “fortunate” to get this opportunity to provide medical supplies and help “to fill the void of overwhelming demand related to Personal Protective Equipment” after the federal government lifted sanctions and tariffs on medical products from China.    “We are committed to keeping the price fixed and as low as possible for US medical companies that purchase from us and we are managing through a number of significant initial orders from New York, California, Arizona, and other states,” Arena said. “We are focused on helping our medical system recover fully and for us all to get back to the important work that we all do.” Parallax, based in Santa Monica, is an outcomes-driven telehealth company that focuses on cost-effective remote diagnosis, treatment and monitoring of patients with chronic diseases. Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham